Showing results (121-130 of 541) with videos related to
Sort By:
Pageof 55
Seminars in Liver Disease|June 11, 2013
Molecular mechanisms of HBV-associated hepatocarcinogenesisFrancesca Guerrieri, Laura Belloni, Natalia Pediconi, et al.Bulletin Du Cancer|September 21, 2020
[Management of immune checkpoint inhibitors-induced liver toxicity in cancer]Fanny Lebossé, Brigitte Bancel, Massimo Levrero, et al.Nature Reviews. Drug Discovery|August 29, 2019
Therapeutic strategies for hepatitis B virus infection: towards a cureGregory C Fanning, Fabien Zoulim, Jinlin Hou, et al.Analytical Biochemistry|September 18, 2023
A fluorescent Ponceau S-based total protein normalization method for conventional and challenging immunoblot samplesClaire Verzeroli, Charlotte A Hernandez, Fabien Zoulim, et al.Nature Reviews. Drug Discovery|January 9, 2020
Author Correction: Therapeutic strategies for hepatitis B virus infection: towards a cureGregory C Fanning, Fabien Zoulim, Jinlin Hou, et al.Viruses|October 14, 2011
Innate antiviral immune responses to hepatitis B virusMalika Ait-Goughoulte, Julie Lucifora, Fabien Zoulim, et al.Nature Reviews. Drug Discovery|June 1, 2013
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseasesLars Petter Jordheim, David Durantel, Fabien Zoulim, et al.Genes|April 4, 2019
Meeting the Challenge of Eliminating Chronic Hepatitis B InfectionPeter A Revill, Capucine Penicaud, Christian Brechot, et al.Journal of Hepatology|February 7, 2006
Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytesOlivier Schorr, Christelle Borel, Christian Trepo, et al.HIV Medicine|October 10, 2023
Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapyLorin Begré, Anders Boyd, Luisa Salazar-Vizcaya, et al.Pageof 55